ES2941036T3 - Composición tópica oftálmica que comprende ácido dobesílico para el tratamiento de enfermedades del segmento posterior del ojo - Google Patents

Composición tópica oftálmica que comprende ácido dobesílico para el tratamiento de enfermedades del segmento posterior del ojo Download PDF

Info

Publication number
ES2941036T3
ES2941036T3 ES18811023T ES18811023T ES2941036T3 ES 2941036 T3 ES2941036 T3 ES 2941036T3 ES 18811023 T ES18811023 T ES 18811023T ES 18811023 T ES18811023 T ES 18811023T ES 2941036 T3 ES2941036 T3 ES 2941036T3
Authority
ES
Spain
Prior art keywords
acid
salt
pharmaceutically acceptable
dobesylic
eye
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES18811023T
Other languages
English (en)
Spanish (es)
Inventor
Nortes Xavier Capdevila
Aquilue Javier Sanagustin
Ganan Maria Isabel Delgado
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorios Salvat SA
Original Assignee
Laboratorios Salvat SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Salvat SA filed Critical Laboratorios Salvat SA
Application granted granted Critical
Publication of ES2941036T3 publication Critical patent/ES2941036T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES18811023T 2017-12-04 2018-11-29 Composición tópica oftálmica que comprende ácido dobesílico para el tratamiento de enfermedades del segmento posterior del ojo Active ES2941036T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17382832 2017-12-04
PCT/EP2018/082999 WO2019110416A1 (en) 2017-12-04 2018-11-29 Ophthalmic topical composition comprising dobesilic acid for treating diseases of the posterior segment of the eye

Publications (1)

Publication Number Publication Date
ES2941036T3 true ES2941036T3 (es) 2023-05-16

Family

ID=60673756

Family Applications (1)

Application Number Title Priority Date Filing Date
ES18811023T Active ES2941036T3 (es) 2017-12-04 2018-11-29 Composición tópica oftálmica que comprende ácido dobesílico para el tratamiento de enfermedades del segmento posterior del ojo

Country Status (24)

Country Link
US (1) US20200390729A1 (https=)
EP (1) EP3720428B1 (https=)
JP (1) JP7846501B2 (https=)
KR (1) KR102756155B1 (https=)
CN (1) CN111542316A (https=)
AU (1) AU2018378981B2 (https=)
BR (1) BR112020011160A2 (https=)
CA (1) CA3083835A1 (https=)
CL (1) CL2020001426A1 (https=)
DK (1) DK3720428T3 (https=)
ES (1) ES2941036T3 (https=)
FI (1) FI3720428T3 (https=)
HR (1) HRP20230319T1 (https=)
HU (1) HUE061852T2 (https=)
MA (1) MA50991B1 (https=)
MX (1) MX2020005809A (https=)
MY (1) MY205498A (https=)
PH (1) PH12020550722A1 (https=)
PL (1) PL3720428T3 (https=)
PT (1) PT3720428T (https=)
SG (1) SG11202004940VA (https=)
SI (1) SI3720428T1 (https=)
WO (1) WO2019110416A1 (https=)
ZA (1) ZA202003944B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202300017430A1 (it) * 2023-08-22 2025-02-22 Service Biotech srl Soluzione oftalmica in forma di collirio contenente una isoforma umana ricombinante di manganese superossido dismutasi (rmnsod) per la cura di patologie dell’occhio
CN117257963B (zh) * 2023-11-02 2024-07-16 广州准优生物科技有限公司 含脐带间充质干细胞外泌体的眼用药剂及其制备方法和用途
CN117643573B (zh) * 2024-01-29 2024-05-03 天津医科大学眼科医院 一种可递送药物至眼后节的纳米滴眼液及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE51421B1 (en) * 1980-08-01 1986-12-24 Smith & Nephew Ass Ophthalmic compositions containing triamterene
US9198886B2 (en) * 2006-08-16 2015-12-01 Pedro Cuevas Sánchez Use of 2,5-dihydroxybenzene for the treatment of ocular diseases
JP2015500213A (ja) 2011-11-30 2015-01-05 ザイジェン インフラメーション リミテッド 眼乾燥症候群を処置するためのｊｎｋシグナル伝達経路の細胞透過性ペプチド阻害剤の使用
EP2777699B1 (en) 2012-02-02 2017-03-29 Invesfovea S.L. Diethylamine-2,5-dihydroxybenzenesulfonate for the treatment of age-related macular degeneration
CA2866405A1 (en) 2012-03-05 2013-09-12 Wayne State University Identification of channelopsin-2 (chop2) mutations and methods of use
RU2014140116A (ru) 2012-04-24 2016-06-10 Тромбодженикс Н.В. Антитела против pdgf-c
EP2875811A1 (en) 2013-11-26 2015-05-27 Luis Antonio Outeirino Miguez Use of dobesilate for treating ocular haemorrhages

Also Published As

Publication number Publication date
SI3720428T1 (sl) 2023-05-31
CA3083835A1 (en) 2019-06-13
EP3720428A1 (en) 2020-10-14
WO2019110416A1 (en) 2019-06-13
KR102756155B1 (ko) 2025-01-20
KR20200096569A (ko) 2020-08-12
ZA202003944B (en) 2022-12-21
PH12020550722A1 (en) 2021-02-15
CN111542316A (zh) 2020-08-14
JP7846501B2 (ja) 2026-04-15
HRP20230319T1 (hr) 2023-05-12
CL2020001426A1 (es) 2020-11-06
AU2018378981A1 (en) 2020-07-16
EP3720428B1 (en) 2023-01-11
BR112020011160A2 (pt) 2020-11-17
MX2020005809A (es) 2020-08-20
HUE061852T2 (hu) 2023-08-28
DK3720428T3 (da) 2023-03-20
US20200390729A1 (en) 2020-12-17
JP2021505554A (ja) 2021-02-18
MA50991B1 (fr) 2023-03-31
FI3720428T3 (fi) 2023-03-30
MA50991A (fr) 2020-10-14
PT3720428T (pt) 2023-04-03
PL3720428T3 (pl) 2023-05-08
MY205498A (en) 2024-10-23
SG11202004940VA (en) 2020-06-29
AU2018378981B2 (en) 2024-10-24

Similar Documents

Publication Publication Date Title
ES2972099T3 (es) Formulación oftálmica
Franca et al. Chitosan/hydroxyethyl cellulose inserts for sustained-release of dorzolamide for glaucoma treatment: In vitro and in vivo evaluation
ES2527791T3 (es) Composición farmacéutica para su uso en oftalmología médica y veterinaria
ES2369554T3 (es) Carboxi-amido-triazoles para el tratamiento local de enfermedades oculares.
US8158609B1 (en) Use of cyclodextrins as an active ingredient for treating dry AMD and solubilizing drusen
EP3454858A1 (en) Combination treatment of ocular inflammatory disorders and diseases
ES2941036T3 (es) Composición tópica oftálmica que comprende ácido dobesílico para el tratamiento de enfermedades del segmento posterior del ojo
CA2487332C (en) Quaternised ammonium cyclodextrin compounds for use as antimicrobial agents, preservatives and penetration enhancers
US10357453B2 (en) Methods of eye treatment using therapeutic compositions containing dipyridamole
US20130281420A1 (en) Ophthalmic Formulations of Squalamine
EP3978003A1 (en) Medical use of 5'-adenosine diphosphate ribose (adpr)
WO2006123676A1 (ja) 角結膜障害の予防または治療剤
KR20190050372A (ko) 압타머 및 항산화 물질의 복합체를 유효성분으로 포함하는 약학 조성물
Nirmal et al. Role of organic cation transporters in the ocular disposition of its intravenously injected substrate in rabbits: implications for ocular drug therapy
ES2712849T3 (es) Composiciones oftálmicas para su uso en el tratamiento del síndrome del ojo seco
KR20160113720A (ko) 황 함유 모이어티를 포함하는 당 유도체 및 이의 제조 방법 및 mps iiic의 치료를 위한 이의 사용 방법
HK40036612A (en) Ophthalmic topical composition comprising dobesilic acid for treating diseases of the posterior segment of the eye
HK40036612B (en) Ophthalmic topical composition comprising dobesilic acid for treating diseases of the posterior segment of the eye
US20230355727A1 (en) Treatment of retinal disorders
CN101432000A (zh) 用于变应性眼病或变应性鼻病的包含三环性三唑并苯并氮杂衍生物的预防剂或治疗剂
CN121969352A (zh) 用于局部眼部使用的凝胶制剂
WO2025127910A1 (es) Formulación de base lipídica de uso tópico oftálmico para incrementar la biodisponibilidad de los antiinflamatorios no esteroideos en los tejidos intraoculares
WO2025231402A1 (en) Methods of inhibiting retinal degeneration
AU2015258244B2 (en) Ophthalmic formulations of squalamine